ImmunityBio, Inc. (IBRX)
NASDAQ · Healthcare
ImmunityBio, Inc. Net Margin 2013–2025
Current and historical net profit margin for ImmunityBio, Inc. (IBRX) over the last 10 years. The current net profit margin for ImmunityBio, Inc. as of December 31, 2025 is -310.18%.
From: 12/31/2013To: 12/31/2025
Revenue
Net Income
Net Margin
ImmunityBio, Inc. Net Margin — FAQ
ImmunityBio, Inc. (IBRX) net margin over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is ImmunityBio, Inc.'s net margin?
ImmunityBio, Inc. (IBRX) reported net margin of -310.2% for fiscal 2025.
Where can I see IBRX's net margin history?
The chart and table above show ImmunityBio, Inc.'s net margin by year and by quarter, including the growth rate.